BCTX
Price
$3.61
Change
+$0.14 (+4.03%)
Updated
Apr 2 closing price
Capitalization
13.17M
KROS
Price
$10.04
Change
+$0.49 (+5.13%)
Updated
Apr 2 closing price
Capitalization
407.24M
28 days until earnings call
Ad is loading...

BCTX vs KROS

Header iconBCTX vs KROS Comparison
Open Charts BCTX vs KROSBanner chart's image
Briacell Therapeutics Corp NEW
Price$3.61
Change+$0.14 (+4.03%)
Volume$25.21K
Capitalization13.17M
Keros Therapeutics
Price$10.04
Change+$0.49 (+5.13%)
Volume$1.15M
Capitalization407.24M
BCTX vs KROS Comparison Chart
Loading...
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCTX vs. KROS commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCTX is a Hold and KROS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (BCTX: $3.61 vs. KROS: $10.04)
Brand notoriety: BCTX and KROS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCTX: 5% vs. KROS: 109%
Market capitalization -- BCTX: $13.17M vs. KROS: $407.24M
BCTX [@Biotechnology] is valued at $13.17M. KROS’s [@Biotechnology] market capitalization is $407.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCTX’s FA Score shows that 1 FA rating(s) are green whileKROS’s FA Score has 0 green FA rating(s).

  • BCTX’s FA Score: 1 green, 4 red.
  • KROS’s FA Score: 0 green, 5 red.
According to our system of comparison, both BCTX and KROS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCTX’s TA Score shows that 4 TA indicator(s) are bullish while KROS’s TA Score has 5 bullish TA indicator(s).

  • BCTX’s TA Score: 4 bullish, 4 bearish.
  • KROS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BCTX and KROS are a good buy in the short-term.

Price Growth

BCTX (@Biotechnology) experienced а -9.98% price change this week, while KROS (@Biotechnology) price change was -8.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.56%. For the same industry, the average monthly price growth was -9.64%, and the average quarterly price growth was -14.03%.

Reported Earning Dates

BCTX is expected to report earnings on Oct 27, 2023.

KROS is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-7.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($407M) has a higher market cap than BCTX($13.2M). KROS YTD gains are higher at: -36.576 vs. BCTX (-57.404). BCTX has higher annual earnings (EBITDA): -27.19M vs. KROS (-185.82M). KROS has more cash in the bank: 560M vs. BCTX (5.01M). BCTX has less debt than KROS: BCTX (27K) vs KROS (18.9M). KROS has higher revenues than BCTX: KROS (3.55M) vs BCTX (0).
BCTXKROSBCTX / KROS
Capitalization13.2M407M3%
EBITDA-27.19M-185.82M15%
Gain YTD-57.404-36.576157%
P/E RatioN/AN/A-
Revenue03.55M-
Total Cash5.01M560M1%
Total Debt27K18.9M0%
FUNDAMENTALS RATINGS
BCTX: Fundamental Ratings
BCTX
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCTXKROS
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 14 days ago
81%
Bullish Trend 15 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FKEMX37.89N/A
N/A
Fidelity Emerging Markets K
GGGIX57.00N/A
N/A
Gabelli Global Growth I
EMQIX8.11N/A
N/A
Ashmore Emerging Markets Active Eq Instl
VEUVX34.74N/A
N/A
JPMorgan Europe Dynamic R6
NRAEX47.79N/A
N/A
Neuberger Berman Sustainable Equity E

BCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCTX has been loosely correlated with SNPX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BCTX jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCTX
1D Price
Change %
BCTX100%
+4.03%
SNPX - BCTX
35%
Loosely correlated
-2.56%
KROS - BCTX
33%
Loosely correlated
+5.13%
MDGL - BCTX
30%
Poorly correlated
+3.28%
AXON - BCTX
30%
Poorly correlated
+3.18%
LSB - BCTX
30%
Poorly correlated
-4.58%
More

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INZY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+5.13%
INZY - KROS
43%
Loosely correlated
+6.48%
AXON - KROS
43%
Loosely correlated
+3.18%
RAPT - KROS
39%
Loosely correlated
-0.85%
DNLI - KROS
39%
Loosely correlated
+11.80%
XENE - KROS
39%
Loosely correlated
+2.68%
More